Abstract
Chronobiology, which is the study of biological rhythms, is perhaps unduly neglected within medicine. It assumes particular importance for diseases, many of them rheumatic diseases and polymyalgia rheumatica [PMR] in particular, where there is clear evidence of a diurnal variation in symptoms. The dramatic improvement in early morning stiffness such that it is invariably abolished by lunchtime even figures in diagnostic criteria sets for PMR.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Cutolo M, Seriolo B, Craviotto C, Pizzorni C, Sulli A. Circadian rhythms in RA. Ann Rheum Dis 2003; 62: 593–596.
Bellamy N, Sothern RB, Campbell J, Buchanan WW. Circadian rhythm in pain, stiffness, and manual dexterity in rheumatoid arthritis: relation between discomfort and disability. Ann Rheum Dis 1991; 50: 243–248.
Bombardieri S, Clerico A, Riente L, Del Chicca MG, Vitali C. Circadian variations of serum myoglobin levels in normal subjects and patients with polymyositis. Arthritis Rheum 1982; 25: 1419–1424.
Bhalla AK. Hormones and the immune response. Ann Rheum Dis 1989; 48: 1–6.
Kirkham BW, Panayi GS. Diurnal periodicity of cortisol secretion, immune reactivity and disease activity in rheumatoid arthritis: implications for steroid treatment. Rheumatol 1989; 28: 154–157.
Perry MG, Kirwan JR, Jessop DS, Hunt LP. Overnight variations in cortisol, interleukin 6, tumour necrosis factor a and other cytokines in people with rheumatoid arthritis. Ann Rheum Dis 2009; 68: 63–68.
Loubaris N, Cros G, Serrano JJ, Boucard M. Circadian and circannual variation of the carregeenin inflammatory effect in the rat. Life Sci 1983; 32: 1349–1354.
Crofford LJ, Kalogeras KTRL. Circadian relationships between interleukin(IL)-6 and ypothalamic-pituitary-adrenal axis hormones: Failure of IL-6 to cause sustained hypercortisolism in patients with early untreated rheumatoid arthritis. J Clin Endocrinol Metab 1997; 82: 1279–1283.
Cutolo M, Maestroni GJM. The melatonin-cytokine connection in rheumatoid arthritis. Ann Rheum Dis 2005; 64: 1109–1111.
Bird HA, Esselinckx W, Dixon AS, Mowat AG, Wood PH. An evaluation of criteria for polymyalgia rheumatica. Ann Rheum Dis 1979; 38: 434–439.
Chuang T-Y, Hunder GG, Ilstrup DM, Kurland LT. Polymyalgia Rheumatica: A 10-Year Epidemiologic and Clinical Study. Ann Intern Med 1982; 97: 672–680.
Healey LA. Long-term follow-up of polymyalgia rheumatica: Evidence for synovitis. Semin Arthritis Rheum 1984; 13: 322–328.
Leeb BF, Rintelen B, Sautner J, Fassl C, Bird HA. The polymyalgia rheumatica activity score in daily use: Proposal for a definition of remission. Arthritis Care Res 2007; 57: 810–815.
Cutolo M, Montecucco CM, Cavagna L, Caporali R, Capellino S, Montagna P, Fazzuoli L. Villaggio B, Seriolo B, Sulli A. Serum cytokines and steroidal hormones in polymyalgia rheumatica and elderly-onset rheumatoid arthritis. Ann Rheum Dis 2006; 65: 1438–1443.
Perfetto F, Moggi-Pignone A, Becucci A, Cantini F, Di Natale M, Livi R, Tempestini A, Matucci-Cerinic M. Seasonal pattern in the onset of polymyalgia rheumatica. Ann Rheum Dis 2005; 64: 1662–1663.
Buttgereit F, Da Silva JAP, Boers M, Burmester G-R, Cutolo M, Jacobs J, Kirwan J, Köhler L, van Reil P, Vischer T, Bijlsma JWJ. Standardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens: Current questions and tentative answers in rheumatology. Ann Rheum Dis 2002; 61: 718–722.
Straub RH, Cutolo M. Review: Involvement of the hypothalamic-pituitary-adrenal/gonadal axis and the peripheral nervous system in rheumatoid arthritis: Viewpoint based on a systemic pathogenetic role. Arthritis Rheum 2001; 44: 493–507.
Arvidson NG, Gudbjörnsson B, Larsson A, Hällgren R. The timing of glucocorticoid administration in rheumatoid arthritis. Ann Rheum Dis 1997; 56: 27–31.
Buttgereit F, Doering G, Schaeffler A, Witte S, Sierakowski S, Gromnica-Ihle E, Jeka S, Krueger K, Szechinski J, Alten R. Efficacy of modified-release versus standard prednisolone to reduce duration of morning stiffness of the joints in rheumatoid arthritis (CAPRA-1): A double-blind randomised controlled trial. Lancet 2008; 371: 205–214.
Bijlsma JWJ, Jacobs JWG. Glucocorticoid chronotherapy in rheumatoid arthritis. Lancet 2008; 371: 183–184.
Hunder GG, Sheps SG, Allen GL, Joyce JW. Daily and alternate-day corticosteroid regimens in treatment of giant cell arteritis: Comparison in a prospective study. Ann Intern Med 1975; 82: 613–618.
Reinberg A, Lévi F. Clinical chronopharmacology with special reference to NSAIDs. Scand J Rheumatol 1987; 16 (Supp. 65): 118–122.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag/Wien
About this chapter
Cite this chapter
Bird, H. (2010). Chronobiology of Polymyalgia Rheumatica and Giant Cell Arteritis. In: Rovenský, J., Leeb, B.F., Bird, H., Štvrtinová, V., Imrich, R. (eds) Polymyalgia Rheumatica and Giant Cell Arteritis. Springer, Vienna. https://doi.org/10.1007/978-3-211-99359-0_8
Download citation
DOI: https://doi.org/10.1007/978-3-211-99359-0_8
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-99358-3
Online ISBN: 978-3-211-99359-0
eBook Packages: MedicineMedicine (R0)